2013 Q2/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Galenica AG
8.2
2 +0 Idenix Pharmaceuticals
8.1
3 +0 Kyowa Hakko Kirin UK
7.9
4 +12 Renovo
7.4
5 +0 Mylan UK
7.2
6 +0 Aptalis Pharma
7.1
7 +5 Biotecnol
7.0
8 +0 Kaken Pharmaceutical
7.0
9 +0 Vectura
6.7
10 +0 Kyorin Holdings
6.7
11 +0 Yakult UK
6.5
12 +0 Questcor
6.5
13 +0 Debiopharm
6.5
14 +0 Meda Pharmaceuticals
6.4
15 +0 Genmab
6.3
16 +0 KRKA
6.2
17 +0 Actelion
6.1
18 +0 Maxygen
6.0
19 +0 Lilly UK
5.9
20 +0 Otsuka Pharmaceuticals Europe
5.8
21 +0 Servier UK
5.7
22 +0 AEterna Zentaris
5.6
23 +0 Cytogen
5.6
24 +0 MorphoSys
5.6
25 +0 Actelion UK
5.6
26 +0 EISAI
5.6
27 +0 Zandu
5.5
28 +0 Stada
5.4
29 +0 Kyowa Hakko Kirin
5.4
30 +0 Taisho Pharmaceutical
5.3
31 +0 Pfizer UK
5.3
32 +0 Galapagos
5.3
33 +0 Dusa Pharmaceuticals
5.1
34 +0 UCB Belgium
5.1
35 +0 Astellas Europe
5.1
36 +0 Recordati
5.1
37 +0 EISAI UK
5.0
38 +0 Stallergenes
5.0
39 +0 ARIAD Pharmaceuticals
5.0
40 +0 Sanofi UK
5.0
41 +0 Dainippon Sumitomo
5.0
42 +20 Fresenius Medical Care
5.0
43 +0 Chugai - Pharma
5.0
44 +0 Otsuka Pharmaceuticals
5.0
45 +0 Cubist Pharmaceuticals
5.0
46 +0 Covence
4.8
47 +0 Imulan Bio Therapeutics
4.8
48 +10 Allergan UK
4.8
49 +0 Bavarian Nordic
4.8
50 +0 InterMune
4.8


Changes in rank are compared to 2013 Q1/Global Life Sciences. Since then, 205 sites entered the survey and 47 sites could not be included in the rankings (2 fewer since last time). Build your own. Report statistics.

We have moved from a Swiss based international table to a more internationally recognised list, this has resulted in significant changes to the members of the Index: